SAN DIEGO, Sept. 2 /PRNewswire-FirstCall/ -- Biosite Incorporated
(Nasdaq: BSTE) today announced that Kim Blickenstaff, chairman and chief
executive officer, and Ken Buechler, president and chief scientific officer,
will discuss the Company's operating environment, new and potential products
and the company's research and development activities at the 2005 Thomas
Weisel Partners Healthcare Tailwinds Conference. Biosite's presentation will
take place Thursday, September 8th, 2005, at 7:55 a.m. Pacific. The
conference is to be held at the Four Seasons Hotel in Boston, Mass.
A link to the live audio webcast can be accessed through the Biosite
website, http://www.biosite.com. The Biosite presentation will be archived on
the website for 21 days in the Investor and Media section under Events
Calendar.
About Biosite Incorporated
Biosite Incorporated is a leading bio-medical company commercializing
proteomics discoveries for the advancement of medical diagnosis. The Company's
products contribute to improvements in medical care by aiding physicians in
the diagnosis of critical diseases and health conditions. Biosite's Triage(R)
rapid diagnostics are used in approximately 50 percent of U.S. hospitals and
in over 50 international markets. Information on Biosite can be found at
http://www.biosite.com.
Biosite(R), Triage(R) and New Dimensions in Diagnosis(R) are registered
trademarks of Biosite Incorporated. The Company's logo is a trademark of
Biosite Incorporated.
SOURCE Biosite Incorporated
 back to top
Related links:
http://www.biosite.com
Company News On-Call:
http://www.prnewswire.com/comp/116737.html
CONTACT:
Nadine Padilla, Vice President, Corporate and
Investor Relations, Biosite Incorporated, +1-858-805-2820,
npadilla@biosite.com
|
